Drugmakers Eisai and Biogen claim success in Alzheimer’s drug study
Pharma groups to seek regulatory approval after trial shows treatment slowed down disease
Full Article
Drugmakers Eisai and Biogen claim success in Alzheimer’s drug study
FT.com
0 shares
1 views
You might like
Related news coverage
Alzheimer's drug shows promise in early results of study
Shares of Biogen and other drugmakers researching Alzheimer's disease soared after Japan's Eisai Co said its potential treatment..
New Zealand Herald
Alzheimer's drug shows promise in early results of study
Shares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday after Japan’s Eisai Co. said its..
SeattlePI.com